Dr. Corinne Epperly has been appointed U.S. chief operating officer, VBL Therapeutics. Dr. Epperly is an oncology expert with industry background in drug development, strategy, commercialization and operations. She will have responsibility in forming VBL’s marketing strategy and commercialization plan for its Phase III candidate VB-111 and will work with VBL’s leadership team to advance corporate strategy and U.S. activities. Dr. Epperly will report to VBL’s chief executive officer, ...